Literature DB >> 32366715

Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment.

Hannah Yejin Kim1,2,3, Shashikant Srivastava4, Hemanth Kumar Ak5, Ben J Marais3,6, Jan-Willem Alffenaar7,2,3.   

Abstract

Entities:  

Keywords:  PK/PD; TDM; drug exposure; linezolid; pharmacokinetics; precision dosing; tuberculosis

Mesh：

Substances：

Year:  2020        PMID： 32366715      PMCID： PMC7318018          DOI： 10.1128/AAC.00287-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Challenging the management of drug-resistant tuberculosis.

Authors:  Hannah Yejin Kim; Scott K Heysell; Stella Mpagama; Ben J Marais; Jan-Willem Alffenaar
Journal:  Lancet       Date:  2020-03-07       Impact factor: 79.321

2.  Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin.

Authors:  Simone H J van den Elsen; Onno W Akkerman; Erwin M Jongedijk; Mireille Wessels; Samiksha Ghimire; Tjip S van der Werf; Daan J Touw; Mathieu S Bolhuis; Jan-Willem C Alffenaar
Journal:  Eur Respir J       Date:  2020-05-07       Impact factor: 16.671

3.  Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report.

Authors:  Sergey Borisov; Edvardas Danila; Andrei Maryandyshev; Margareth Dalcolmo; Skaidrius Miliauskas; Liga Kuksa; Selene Manga; Alena Skrahina; Saulius Diktanas; Luigi Ruffo Codecasa; Alena Aleksa; Judith Bruchfeld; Antoniya Koleva; Alberto Piubello; Zarir Farokh Udwadia; Onno W Akkerman; Evgeny Belilovski; Enrique Bernal; Martin J Boeree; Julen Cadiñanos Loidi; Qingshan Cai; Jose Joaquín Cebrian Gallardo; Masoud Dara; Edita Davidavičienė; Lina Davies Forsman; Jorge De Los Rios; Justin Denholm; Jacinta Drakšienė; Raquel Duarte; Seifeldin Eltaeb Elamin; Nadia Escobar Salinas; Maurizio Ferrarese; Alexey Filippov; Ana Garcia; José-María García-García; Ieva Gaudiesiute; Blagovesta Gavazova; Regina Gayoso; Roscio Gomez Rosso; Vygantas Gruslys; Gina Gualano; Wouter Hoefsloot; Jerker Jonsson; Elena Khimova; Heinke Kunst; Rafael Laniado-Laborín; Yang Li; Cecile Magis-Escurra; Vinicio Manfrin; Valentina Marchese; Elena Martínez Robles; Alberto Matteelli; Jesica Mazza-Stalder; Charalampos Moschos; Marcela Muñoz-Torrico; Hamdan Mustafa Hamdan; Birutė Nakčerienė; Laurent Nicod; Magnolia Nieto Marcos; Domingo Juan Palmero; Fabrizio Palmieri; Apostolos Papavasileiou; Marie-Christine Payen; Agostina Pontarelli; Sarai Quirós; Adrian Rendon; Laura Saderi; Agnese Šmite; Ivan Solovic; Mahamadou Bassirou Souleymane; Marina Tadolini; Martin van den Boom; Marisa Vescovo; Pietro Viggiani; Askar Yedilbayev; Rolandas Zablockis; Dmitry Zhurkin; Matteo Zignol; Dina Visca; Antonio Spanevello; José A Caminero; Jan-Willem Alffenaar; Simon Tiberi; Rosella Centis; Lia D'Ambrosio; Emanuele Pontali; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2019-12-19       Impact factor: 16.671

4.  Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment.

Authors:  Mathieu S Bolhuis; Onno W Akkerman; Marieke G G Sturkenboom; Samiksha Ghimire; Shashikant Srivastava; Tawanda Gumbo; Jan-Willem C Alffenaar
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

5.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

6.  Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.

Authors:  Shashikant Srivastava; Gesham Magombedze; Thearith Koeuth; Carleton Sherman; Jotam G Pasipanodya; Prithvi Raj; Edward Wakeland; Devyani Deshpande; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.

Authors:  Andreas H Diacon; Veronique R De Jager; Rodney Dawson; Kim Narunsky; Naadira Vanker; Divan A Burger; Daniel Everitt; Frances Pappas; Jerry Nedelman; Carl M Mendel
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191
  7 in total
  1 in total

1.  Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".

Authors:  Andreas H Diacon; Veronique R De Jager; Rodney Dawson; Kim Narunsky; Naadira Vanker; Divan A Burger; Daniel Everitt; Frances Pappas; Jerry Nedelman; Carl M Mendel
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.